Skip to main content

Table 2 Effect of pyridoxine on the fatty acid composition in erythrocyte membranes

From: Variations in the lipid profile of patients with chronic renal failure treated with pyridoxine

  

Days of treatment

 

Fatty acid

Basal 1

30

60

Basal 2

16:0

22.0 ± 1.0a

19.0 ± 1.3a

17.0 ± 1.4b

23.8 ± 0.9a

16:1

0.3 ± 0.05a

1.0 ± 0.2b

1.0 ± 0.1b

1.3 ± 0.2b

18:0

20.4 ± 0.3a

22.0 ± 0.5b

23.0 ± 0.4b

19.3 ± 0.2c

18:1

14.7 ± 0.4

14.3 ± 0.5

14.7 ± 1.3

14.2 ± 0.6

18:2 n-6

10.7 ± 0.4

11.0 ± 0.5

10.5 ± 1.0

10.6 ± 0.5

20:3 n-6

1.9 ± 0.1

1.6 ± 0.1

2.1 ± 0.2

1.6 ± 0.1

20:4 n-6

19.4 ± 0.9a

19.0 ± 0.7a

20.6 ± 0.7a

15.7 ± 0.7b

22:4 n-6

0.5 ± 0.1a

0.4 ± 0.05a

0.5 ± 0.1a

0.2 ± 0.02b

22:5 n-6

4.7 ± 0.5

4.1 ± 0.3

4.7 ± 0.3

3.5 ± 0.2

22:5 n-3

2.6 ± 0.2a

2.3 ± 0.2ab

2.6 ± 0.2a

1.9 ± 0.1b

22:6 n-3

4.7 ± 0.3

5.6 ± 0.5

5.0 ± 0.5

4.2 ± 0.3

  1. Results are the means of 12 determinations ± 1 SEM expressed as μg % of total fatty acids. Fatty acids are identified by: number of carbon atoms in the chain is given first, value following the colon represents number of double bonds (zero means saturated fatty acid); number following n- indicates the position of the last double bond counting the double bond from the terminal methyl group. Values not bearing the same superscript letter are significantly different at P < 0.05.